Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases. - Wikidata - awgldk - TriplyDB

Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.

Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.

http://www.wikidata.org/entity/Q39173082

about

Fluorescent imaging of cancerous tissues for targeted surgery.Targeted nanotechnology for cancer imaging.Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy Emerging applications of porphyrins in photomedicine Phototheranostic Porphyrin Nanoparticles Enable Visualization and Targeted Treatment of Head and Neck Cancer in Clinically Relevant Models.Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging.Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy.Nanomedical engineering: shaping future nanomedicines.An MRI-sensitive, non-photobleachable porphysome photothermal agent.Nanoparticle-Enabled Selective Destruction of Prostate Tumor Using MRI-Guided Focal Photothermal Therapy.Targeting tumor metastases: Drug delivery mechanisms and technologies.Radiolabelled porphyrins in nuclear medicine.Advanced Functional Nanomaterials for Theranostics.Porphyrin-loaded nanoparticles for cancer theranostics.Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy.Combined Positron Emission Tomography and Cerenkov Luminescence Imaging of Sentinel Lymph Nodes Using PEGylated Radionuclide-Embedded Gold Nanoparticles.An Integrated Nanotechnology-Enabled Transbronchial Image-Guided Intervention Strategy for Peripheral Lung Cancer.Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma.Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy.Effect of removing Kupffer cells on nanoparticle tumor delivery.Multimodal Nanoparticle for Primary Tumor Delineation and Lymphatic Metastasis Mapping in a Head-and-Neck Cancer Rabbit Model.In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging.Porphysome nanoparticles: Tailoring treatments with nature’s pigments

P2860

Q26830905-90B4D853-9B35-4F88-B80A-054892924258 Q27010317-515351D9-E307-41A5-879E-8061E7076115 Q28066010-A638B1EA-9243-4115-BA59-47AF92404A9A Q30355707-27F2E454-474A-4CC7-ACDD-FE3EB4E8AE52 Q30395878-B3DE8254-EE5B-477D-9F90-DA1596903A64 Q30857901-3BFAC64B-20FB-4377-9153-32AB8E5B8C8F Q34104295-1C64FA44-9932-41F6-A719-55EF73742779 Q35019550-A209D070-9C7A-4A32-A7FC-E31ABFD4F6C5 Q35170787-1764A8C3-0BE4-4201-A6D8-7E0CD52493E0 Q36023165-B4567B0E-B6A9-4F12-9B2F-0A4094F3CF03 Q36557855-DF829FB2-7DCF-4801-8204-670C3387BD0B Q38172477-B0B9F338-9454-4423-97F1-CD07F8ACC7F4 Q38639877-CD7B033F-0453-489A-817B-8908A4F37958 Q38686870-0F2D598A-D57A-4CE8-BD3D-156B058B102F Q38926681-E33A7D8F-FF51-43D8-ADA6-666F0E10E7CA Q39030427-AE24E26B-F253-45BA-888E-287C4B4A7133 Q39579062-255F2833-91B0-4AE7-8EFC-086E370463F3 Q41318171-B8CE44BC-167B-4FA0-9091-1BBE32FC8939 Q42362427-2ABBB36B-0DC1-4520-8D9F-BB25265A522B Q45986152-B8063E02-0420-4593-9208-F857D8B52B56 Q47280975-71468001-54C1-422F-BF08-296E43E693AC Q51804882-8EA9BEEB-6C99-4898-86A0-1B8AF5DB7349 Q53018516-253B99C7-64EB-495A-B1A7-75445F0E8CCA Q59159030-0307D3AF-0045-4A4D-9D72-BE745C4B6142

P2860

Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.

http://www.wikidata.org/entity/Q39173082

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Inherently multimodal nanopart ...... te tumors and micrometastases.

@en

Inherently multimodal nanopart ...... te tumors and micrometastases.

@nl

type

label

Inherently multimodal nanopart ...... te tumors and micrometastases.

@en

Inherently multimodal nanopart ...... te tumors and micrometastases.

@nl

prefLabel

Inherently multimodal nanopart ...... te tumors and micrometastases.

@en

Inherently multimodal nanopart ...... te tumors and micrometastases.

@nl

P1433

Q39173082-A456CCD1-4A12-4F05-ADF3-331A1B782670

P1476

Q39173082-4988A44D-254E-41AB-927F-6F4A946D26F0

P2093

Q39173082-50C997A3-6B08-4193-B086-1F20EE4319E0

Q39173082-6EEF00A6-03E8-4E00-8044-4A6490BC9184

Q39173082-701B9F77-5B36-4E0A-B131-17AED127C8DA

Q39173082-B371E3CD-88FD-42BC-A5E3-1BA7B905EE95

P2860

Q39173082-00753215-06A4-4982-ADD0-908E92D2AA67

Q39173082-022B244A-DFED-44A4-9876-47F62F9B018F

Q39173082-071C431A-1634-41CE-80AE-FFC3018F4578

Q39173082-09D8E020-0656-46BC-92B6-F5CC1669264A

Q39173082-10C28F31-0D96-4C41-A98E-98214660352B

Q39173082-1755383D-0241-4416-B28D-7792EA10333E

Q39173082-185D17C9-0070-4F97-B072-DA39781605A3

Q39173082-1B0FFBAC-BD0D-4FE3-8279-0B10ED4347AA

Q39173082-1E773894-BEAC-42F6-90C5-A5D7C632B513

Q39173082-2A8B192E-C955-491C-A5CB-473BD8E40E60

P304

Q39173082-61F8D5F4-1E7F-4FC3-BF51-F1C33D7B266A

P31

Q39173082-42583131-EF2D-4DC7-A842-5E9088B6110D

P356

Q39173082-EB4E1A74-777F-40D5-B84A-EF417ECD4C61

P407

Q39173082-4AC31430-A674-4575-AB46-4F654F227AA1

P433

Q39173082-FEA9B38A-3363-42AA-9E36-635FD16846D1

P478

Q39173082-DD6198F9-BE53-44DB-95BD-0D240AFCADFB

P50

Q39173082-5E1E3678-21F6-4FCC-960A-F35BA583087C

Q39173082-60136063-7248-475B-996B-76B9CAD51901

Q39173082-942B42BA-843F-4F34-BDB2-AB6F14328DA0

P577

Q39173082-FDA47A4E-C450-4207-A331-8E808D07FBE5

P5875

Q39173082-A9120F03-D19A-4976-8432-45C5C06083E7

P698

Q39173082-BED18E27-C2AD-47DF-A4F5-5AD308AEF05A

P921

Q39173082-7DC89F27-E7D5-40C1-BA55-EA1744CE3776

P932

Q39173082-FA6F974D-368D-4734-924B-DF3F148771B0

P356

P1433

P1476

Inherently multimodal nanopart ...... te tumors and micrometastases.

@en

P2093

Cheng S Jin

http://www.w3.org/2001/XMLSchema#string

Joseph M Gold

http://www.w3.org/2001/XMLSchema#string

Thomas D Macdonald

http://www.w3.org/2001/XMLSchema#string

Tracy W Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging in the era of molecular oncology.

Active surveillance for prostate cancer: progress and promise

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

Cancer statistics, 2009

Nanoparticle therapeutics: an emerging treatment modality for cancer

Screening and prostate-cancer mortality in a randomized European study

Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate.

Image guided photothermal focal therapy for localized prostate cancer: phase I trial.

Focal therapy in prostate cancer: modalities, findings and future considerations.

Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents.

P304

4221-4232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NN400669R

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Brian C. Wilson

Robert G. Bristow

P577

2013-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236096080

http://www.w3.org/2001/XMLSchema#string

P698

23544841

http://www.w3.org/2001/XMLSchema#string

P921

P932

3667620

http://www.w3.org/2001/XMLSchema#string